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Summary
 
The majority (
 
z
 
70%) of postselection CD4
 
1
 
 single-positive (SP) thymocytes are CD8
 
lo
 
CD4
 
hi
 
.
These cells express very low levels of CD8, undetectable by flow cytofluorimetric (FCM) anal-
ysis, but sufficiently high to allow purification by panning. Unlike the fully mature
CD8
 
2
 
CD4
 
hi
 
 thymocytes, which account for the remaining 
 
z
 
30% of the SP CD4
 
1
 
 thy-
mocytes, CD8
 
lo
 
CD4
 
hi
 
 cells are functionally immature and short-lived unless they receive an
unidentified maturation signal from the thymus. In this study, we tested the hypothesis that this
signal is provided by a T cell receptor (TCR)–major histocompatibility complex (MHC) class
II interaction. Using intrathymic transfer, we show that the immature CD8
 
lo
 
CD4
 
hi
 
 cells could
complete their intrathymic maturation and populate the peripheral lymphoid organs in the ab-
sence of MHC class II (and class I) molecules. Furthermore, in mice devoid of class II (and class
I) molecules, the progeny of CD8
 
lo
 
CD4
 
hi
 
 cells was long-lived and functionally reactive to allo-
geneic class II molecules, although their numbers in the spleen and the mesenteric lymph node
were 
 
z
 
40–50% lower than those in class II
 
1
 
 mice 5 mo after transfer. Control experiments
demonstrated that the surviving cells did not originate from the contaminating mature thy-
mocytes. These results demonstrate that the final maturation, proliferation, and peripheral sur-
vival (up to 5 mo) of at least some postselection CD4
 
1
 
 SP cells do not require the TCR–MHC
class II interaction. They also indicate that the TCR–MHC class II interaction(s) required for
the intrathymic development of long-lived CD4
 
1
 
 SP cells occurs before the CD4
 
hi
 
 SP stage of
development.
Key words: CD4 thymocytes • T cell receptor • T cell development • major histocompatibility 
complex class II
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T
 
cell receptor (TCR)-
 
a
 
/
 
b
 
 lymphocytes develop in the
thymus from immature bone marrow–derived precur-
sors, via a series of phenotypically identifiable maturational
steps (1–3). After intrathymic development, successfully se-
lected T cells are exported to the periphery where they
play a central role in the immune response (4). The most
mature intrathymic T cells comprise the CD4
 
2
 
CD8
 
1
 
 and
CD4
 
1
 
CD8
 
2
 
 thymocytes, which recognize Ag presented
by MHC class I and II molecules, respectively. Both cell
subsets were initially believed to be fully immunocompe-
tent cells on their way to the periphery (for a review, see
reference 4). Subsequently, several findings demonstrated
that such a view was oversimplified. First, many murine
single-positive (SP)
 
1
 
 thymocytes remain in the thymus for
 
z
 
13–14 d (5, 6), which accounts for about half the time
they spend in this organ. Second, only 
 
z
 
6% of the SP thy-
mocytes are potentially exportable at any given time, sug-
gesting that selective requirements for export of the other
94% are yet to be satisfied (7, 8). SP thymocytes (9) were
also found to proliferate in the fetal organ culture (10) and
in vivo (11), suggesting that these cells may still be receiv-
ing signals from the thymus. In parallel, several studies
showed that most of the CD4 SP cells in the thymus are
functionally immature (12–15). Finally, it was demon-
strated that in vivo the immature, CD8
 
lo
 
CD4
 
hi
 
 thymocytes
require signals from the thymic microenvironment to be-
come immunocompetent long-lived CD8
 
2
 
CD4
 
hi
 
 cells (9).
 
and class II molecules; DC, dendritic cell; DP, CD8
 
1
 
CD4
 
1
 
 double-posi-
tive; FCM, flow cytofluorometry; M
 
f
 
, macrophage(s); MFI, mean fluo-
rescence intensity; mLN, mesenteric LN; SP, single-positive.
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; CII
 
2
 
, MHC class II–defi-
cient by gene targeting disruption; CI/II
 
2
 
, deficient for both MHC class I 
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Final Intrathymic Maturation of CD4
 
1
 
 Cells Is Class II Independent
 
In this study, we investigated the role of the TCR–
MHC class II contact in the interaction between the in-
completely mature CD8
 
lo
 
CD4
 
hi
 
 thymocytes and the thy-
mic microenvironment. The design of these experiments
also led to insights into the longevity and function of the
resulting CD4
 
1
 
 lymphocytes in a peripheral environment
devoid of MHC class II or both class I and II molecules.
Our results clearly demonstrate that at least some of the
CD8
 
lo
 
CD4
 
hi
 
 thymocytes can complete their maturation in
the absence of such contacts, and that they only require in-
trathymic contact with class II molecules before the CD4
 
1
 
SP stage to become functional CD4
 
1
 
 SP lymphocytes. Fur-
thermore, these cells were able to proliferate and survive in
substantial numbers in the peripheral compartment of
MHC class I/II–deficient (CI/II
 
2
 
) mice for at least up to 5
mo after transfer, indicating that at least some class II–
restricted CD4
 
1
 
 T cells do not depend on MHC class II
molecules for peripheral survival.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) mice and their Ly-5.2 congenic variant
(B6.Ly-5.2) were purchased from the National Cancer Institute
animal facility (Frederick, MD). Class II–deficient (CII
 
2 
 
[16])
mice and class I/II–deficient mice on a B6 background (12th
backcross, CI/II
 
2 
 
[17]) were purchased from Taconic Farms. The
B6 Thy-1 congenic variant strain, B6.PL–thy-1
 
a
 
 Cy, as well as
the mice genetically deficient in the CD4 gene (18), which were
used as class II
 
1
 
 recipients, and the natural H-2K
 
b
 
 and H-2 I-A
 
b
 
coisogenic variants of B6 mice, B6.C–H-2
 
bm1
 
 (bm1) and B6.C–
H-2
 
bm12
 
 (bm12), respectively, which were used as stimulators in
the MLR, were purchased from The Jackson Laboratory. Female
mice, between 7 and 10 wk of age, were used in all experiments.
 
Antibodies, Reagents, Cell Separation, and Flow Cytofluorometry.
 
The allele-specific anti-Ly5.1 (104-2.1) and anti-Ly5.2 (A20-7.1)
mAbs (19; obtained from Dr. U. Hammerling, Memorial Sloan-
Kettering Cancer Center) were produced as ascitic fluid, purified,
and conjugated to FITC or biotin in our laboratory. All other an-
tibodies were purchased from PharMingen. Anti-CD4–conju-
gated microbeads, the VS
 
1
 
 and RS
 
1
 
 separation columns, and
the SuperMacs
 
®
 
 separation device were purchased from Miltenyi
Biotec and were used per the manufacturer’s instructions. All
other antibodies and reagents, as well as the cytotoxic elimination
of CD8
 
hi/med
 
 cells by mAb 
 
1
 
 C
 
9
 
 and separation of the resulting
population into CD8
 
lo
 
 and CD8
 
2
 
 by panning, were described
previously (9). CD4
 
hi
 
 populations from each subset were then
purified to 
 
.
 
99% purity, either by flow cytometry (FCM) using
a Mo-Flo sorter (Cytomation), or by two sequential immuno-
magnetic bead sorting steps using the VS
 
1
 
 separation columns
and anti-CD4–conjugated microbeads (Miltenyi Biotec), as indi-
cated. For the cell sorting, cells were stained with mAbs against
CD4, CD11c
 
1
 
, and MHC class II, and were sorted to obtain a
CD4
 
hi
 
 class II
 
2
 
 CD11c
 
2
 
 fraction. Upon reanalysis, these cells
contained 
 
,
 
0.1% cells positive for class II, CD11b, or CD11c,
and were used for Exp. 2 in Tables I–III. CD8
 
2
 
CD4
 
hi
 
 cells were
used in the intravenous transfer experiment to confirm the strin-
gency of cell purification, and in the intrathymic “spiking” ex-
periment aimed to test the role of contaminating cells; the
CD8
 
lo
 
CD4
 
hi
 
 cells were used for intravenous and intrathymic
transfers.
 
Intrathymic Injection, Adult Thymectomy, and In Vivo Antibody
Depletion.
 
B6 mice were depleted of CD4 cells using two intra-
peritoneal injections of 100 
 
m
 
l (
 
z
 
500 
 
m
 
g) mAb GK1.5 in the
form of ascites, 2 d apart. Antibody-injected mice were then
rested for 4 wk before they entered the experiment to allow
elimination of the antibody. They were subsequently used as re-
cipients for intrathymic transfers or were also thymectomized and
used as recipients for the intravenous transfer. Genetically defi-
cient mice (CD4
 
2
 
, CII
 
2
 
, and CI/II
 
2
 
) used as recipients were not
pretreated before intrathymic transfer. Intrathymic injections
were performed as described (20, 21), with 0.85–2 
 
3
 
 10
 
6
 
 thy-
mocyte subsets of the B6.Ly-5.2 and/or B6.PL origin injected
into each thymic lobe. The thymectomies were performed using
the same surgical approach as for the intrathymic injections, ex-
cept that vacuum suction was applied to remove the organ. Killed
mice were dissected to verify the removal of the thymus.
 
Phenotypic and Functional Analysis of the Peripheral CD4
 
1
 
 T
Cells.
 
4–5 mo after intravenous or intrathymic transfer, spleens
and mesenteric lymph nodes (mLNs) from the recipient mice
were used to analyze the phenotype and function of CD4 T cells.
Phenotypic analysis was performed by FCM, using anti-CD4 and
donor- and recipient-specific Ly-5 mAbs, using a FACScan™ in-
strument (Becton Dickinson) equipped with the Lysys II
 
®
 
 soft-
ware, as described previously (9).
For functional analysis, donor-derived CD4
 
1
 
 cells were mag-
netically purified from the pooled spleens of the recipients, using
FITC-labeled donor allele–specific mAbs, followed by the anti-
FITC–conjugated paramagnetic microbeads and the RS
 
1
 
 separa-
tion columns (Miltenyi Biotec). 10
 
5
 
 cells/well were seeded in a
flat-bottomed 96-well plate, alone or with 2 
 
3
 
 10
 
5
 
 irradiated (30
Gy) nucleated spleen cells of bm1, bm12, or B6 origin. The as-
says were done in quadruplicate. Culture supernatants were col-
lected 72 h later and frozen for subsequent IL-2 quantification by
using the IL-2–dependent CTLL indicator line. 5 
 
3 
 
10
 
3
 
 CTLL
cells were incubated in a 1:1 dilution of the supernatants for 18 h,
the last 6 h in the presence of 1 
 
m
 
Ci of 
 
3
 
H-TdR (New England
Nuclear). The cells were then harvested, and the degree of incor-
poration of radioactive thymidine was determined in a beta-
counter (Amersham Pharmacia Biotech).
 
Results
 
To investigate the role of MHC class II molecules in the
final maturation of incompletely mature CD8
 
lo
 
CD4
 
hi
 
 thy-
mocytes, these cells were intrathymically transferred into
recipients genetically deficient in MHC class II molecules.
To that effect, CD8
 
lo
 
CD4
 
hi
 
 and CD8
 
2
 
CD4
 
hi
 
 thymocytes
were purified (
 
.
 
99%) from B6.Ly-5.2 mice, as described
in Materials and Methods. The key separation step was
achieved by panning, and, in our hands, this was found to
be the most reliable method of separating these two func-
tionally nonoverlapping subsets. By FCM, the phenotype
of these two subsets was characteristic of that described pre-
viously (Fig. 1 of this paper, data not shown, and Figure 1
in reference 9): both subsets were CD8
 
2
 
CD4
 
hi
 
TCR-
 
ab
 
hi
 
by FCM, but the CD8
 
lo
 
CD4
 
hi
 
 cells contained more
CD69
 
1
 
 cells and expressed higher levels of CD24 and
somewhat lower levels of CD44 than CD8
 
2
 
CD4
 
hi
 
 thy-
mocytes (not shown). However, as shown previously (9),
most of these molecules are expressed by both subsets in at
least partly overlapping fashion. We observed that the most759 Dyall and Nikoli - ugi c ´ Z ˘ c ´
consistent difference in the phenotype of these two subsets
was in the level of expression of CD45RB: the levels ob-
served on CD82CD4hi cells were more than twice higher
than those on CD8loCD4hi thymocytes (mean fluorescence
intensity [MFI] 151 and 341, respectively; Fig. 1 B), similar
to the findings of Penit’s group (15). This feature correlates
very well with the difference in functional responsiveness
of the two subsets and the function of CD45: the former
subset is functionally mature, whereas the latter cannot re-
spond with the full spectrum of functional activities (12).
To further confirm the identity of the above purified cell
populations, both subsets were transferred intravenously
into thymectomized and CD4-depleted syngeneic recipi-
ents. Under such circumstances, only the CD82CD4hi thy-
mocytes can give long-term (.1 mo) repopulation of the
peripheral lymphoid organs, whereas the CD8loCD4hi cells
disappear 3–4 wk after transfer (9). Results shown in Ta-
ble I confirmed this finding, and demonstrated that the
CD8loCD4hi thymocyte subset isolated in this study was
phenotypically and functionally indistinguishable from the
previously described cells (9, 12). Moreover, results of this
experiment demonstrate that the cross-contamination and
outgrowth of the contaminating cells between the two
subsets isolated as described in Materials and Methods was
negligible or nonexistent, as the putative progeny of the
cross-contaminating CD82CD4hi cells was not detectable
4–5 mo after injection of purified CD8loCD4hi cells.
CD8loCD4hi thymocytes from the same cellular prepara-
tion were also injected into the thymi of control class II1
CD42/2 recipients, which express wild-type levels of the
MHC class II molecules (but lack CD41 T cells [18], thus
facilitating the detection of CD41 progeny of the injected
cells), or of the CII2 recipients, which genetically lacked
these molecules (and consequently only had very low
CD41 numbers, owing to a severe defect in CD4 T cell
positive selection [16]). In both types of recipient, injected
immature CD8loCD4hi thymocytes yielded long-lived
progeny that populated the peripheral lymphoid organs
(Table II, Exp. 1). Therefore, class II molecules appeared
not to be necessary either for the terminal differentiation of
CD4hi thymocytes or for their survival in the periphery.
Again, a caveat to this conclusion was the long time course
of our experiment, which was conducive for the out-
growth of a minor population of contaminating CD82
CD4hi thymocytes. Although the results shown in Table I
strongly argue against this possibility, we performed an-
other control experiment in which we deliberately spiked
the transferred CD8loCD4hi cells with Thy-1 congenic
(Thy-1.1) CD82CD4hi thymocytes. When we added 1%
CD82CD4hi thymocytes to the sorted .99% pure
CD8loCD4hi thymocytes, we could not detect the progeny
of the admixed Thy-1.1 cells (Table II). The progeny of
10% contaminating cells was detectable, but these cells
showed no selective proliferative advantage: their represen-
tation remained at or below the 10% level among the trans-
ferred thymocytes even after 5 mo in vivo (Table II).
Therefore, the above results cannot be accounted for by
the contaminating mature thymocytes. Another possibility
was that we transferred a substantial number of class II1
cells with our thymocytes. However, cells transferred in
Exp. 2 (Table II) were sorted to exclude class II1 and
CD11c1 cells, and, after sorting, contained no cells positive
for class II, for the dendritic cell (DC) marker CD11c, or
the macrophage (Mf) marker CD11b (,0.1% in Exp. 2,
Table II [see legend]). Coupled with the fact that the turn-
over of class II1 cells (DCs, B cells, and Mf) is relatively
rapid and certainly complete within 1 mo, it is extremely
unlikely that those cells could have promoted the final mat-
uration of CD4 thymocytes in the thymus and/or the pe-
riphery.
Figure 1. FCM profile of puri-
fied CD8loCD4hi thymocytes used
for intrathymic injection. Total
B6.Ly-5.2 thymocytes were frac-
tionated by cytotoxic depletion of
CD8hi cells with mAb 1 C9, fol-
lowed by panning for the cells
coated with the antibody and
therefore still expressing low lev-
els of CD8, and the final immu-
nomagnetic sorting step using
two rounds of purification with
anti-CD4 mAb–coated paramag-
netic beads (Miltenyi Biotec). (A)
Obtained cells were stained for
the expression of CD4 and CD8,
and the FCM profile is shown in
the figure as the 12% probability
plot using the Lysys II® software
program (Becton Dickinson).
These cells were then used for the
intrathymic and intravenous transfer in Exp. 2 shown in Tables I–III. Percentages denote the distribution of cells into the four major CD8/4-defined
populations. (B) Histograms depicting expression of CD45RB on CD82CD4hi (thick line, MFI 5 341) and CD8loCD4hi thymocytes (thin line, MFI 5
151) isolated as described in Materials and Methods. Cells were stained to reveal expression of CD4, CD8, and CD45RB, and the results were obtained
without gating on CD4 cells, because virtually all cells were CD82CD41 by FCM.760 Final Intrathymic Maturation of CD41 Cells Is Class II Independent
A possibility also existed that MHC class I molecules
may provide critical signals to keep CD41 T cells alive in
the peripheral organs. To test this possibility, we used CI/
II2 mice as recipients for thymocytes. Interestingly, upon
such transfer, we recovered more CD4 T cells than when
recipients only lacked class II molecules (Table II), similar
to the results of a recently published study (22). It is possi-
ble that the complete lack of T cells, observed in CI/II2
mice (17), may be conducive to an even more extensive
expansion than the one occurring in CII2 mice. Indeed,
from the spleen only we recovered amounts of CD4 cells
that were tenfold higher than those injected intrathymi-
cally. However, one caveat of this experiment is that the
injected CD4 cells themselves expressed class I, as they
were derived from the class I1 mice (this was the only way
to unambiguously ascertain the donor origin of these cells);
therefore, their contact with each other could have pro-
vided the survival signal. However, at a minimum, we can
still reliably conclude that the presence of the MHC mole-
cules on stromal cells or on APCs is not necessary for either
the terminal CD4 thymocyte differentiation or the survival
of at least some CD4 T cells in the periphery.
To test whether the peripheral CD4 progeny of the
CD8loCD4hi thymocytes was functional in the absence of
MHC molecules, we isolated .99% pure CD41Ly-5.21
donor-derived cells from the recipient mice, stimulated
them with allogeneic cells in vitro, and measured the IL-2
release in response to such stimulation (Table III). CD4
cells of donor origin produced IL-2 at levels comparable to
those produced by unmanipulated peripheral CD4 cells, es-
tablishing that these cells were functional and immuno-
competent. The fact that donor-derived CD41Ly5-21 cells
responded vigorously to MHC class II–disparate I-Abm12
stimulators, but not to the class I–disparate Kbm1 stimulators
(Table III, Exp. 2) clearly demonstrated that their precur-
sors must have been appropriately positively selected on
MHC class II molecules before the point of transfer. Simi-
lar results were obtained with the donor-derived CD4 T
cells recovered from the CI/II2 recipients (data not
shown).
Discussion
The primary objective of this study was to investigate the
dependence of the final phase of intrathymic maturation on
MHC class II molecules. Several reports indicated that the
TCR–MHC contact must be maintained throughout sev-
eral discrete stages in T cell development, but none of these
has addressed the importance of this contact for terminal
maturation of SP cells. As pointed out in our previous pub-
lications (9, 12), the CD8loCD4hi cells in our studies differ
significantly from the cells called CD8loCD41 (23–25):
theirs correspond to the CD8intCD4hi cells, which bear lev-
els of CD8 lower than those on double-positive (DP) thy-
mocytes but clearly detectable by FCM. Many of these
latter cells actually belong to the CD8 lineage. The
CD8loCD4hi cells studied here belong to the CD4 lineage
and score within the CD4 SP population by FCM: their
CD8 levels are undetectable by FCM (for a full phenotypic
difference between our CD8loCD4hi cells and the CD8lo
CD41 cells of the other authors, see reference 9). Our data
resolve the class II dependence of the last phase of intrathy-
mic maturation of SP CD4 thymocytes unambiguously: no
MHC class II–TCR contact is required for this late differ-
entiation. This conclusion is further supported by the re-
cent data of Hare et al. in the reaggregation organ culture
system (26), showing that thymocytes at or past the CD691
DP stage no longer require contact with class II molecules
to become functional CD4 SP thymocytes. At present, we
can only speculate on the nature of the final maturation sig-
nal. Among the obvious contenders are the cytokines, the
costimulatory molecules, and/or the matrix–integrin inter-
actions, some of which are currently being investigated.
Survival and peripheral homeostasis of T cells were not
the key subjects of this study. However, our results beg a
discussion of these issues. Perhaps surprisingly, the periph-
 
Table I. Functional Characterization of the CD8loCD4hi and 
CD82CD4hi Thymocyte Subsets Isolated in This Study
Donor cells
Mouse 
no.
Percent donor CD41 cells in
Exp. 1 mLN Spleen
CD82CD4hi 1 7.0 2.0
2 11.0 3.0
Mean 9.0 6 2.0 2.5 6 0.3
CD8loCD4hi 1 0.2 0.0
2 0.6 0.1
3 0.8 0.0
4 0.5 0.0
5 0.0 0.0
Mean 0.4 6 0.4 0.0 6 0.1
Exp. 2
CD82CD4hi 1 6.3 2.0
2 5.5 1.9
3 7.2 2.5
Mean 6.3 6 0.9 2.2 6 0.3
CD8loCD4hi 1 0.0 0.0
2 0.0 0.0
3 0.0 0.0
Mean 0.0 6 0.0 0.0 6 0.0
2 3 106 donor B6.Ly-5.2 cells of either subset were injected in the tail
vein of B6 mice that were previously thymectomized, and depleted of
CD4 cells by mAb treatment. 4 mo (Exp. 1) or 5 mo (Exp. 2) later, the
recipients were analyzed by FCM, using CD4 and Ly-5 allele–specific
antibodies, as described in Materials and Methods.761 Dyall and Nikoli - ugi c ´ Z ˘ c ´
Table II. CD8loCD4hi Thymocytes Do Not Require MHC Class II Molecules for Final Intrathymic Maturation and Survival in the 
Peripheral Lymphoid Organs
Exp. 1 Recipients Mouse no. 
Percent donor CD41 cells in
No. of donor CD41 cells 
(Spleen 1 mLN 3 106)* mLN Spleen
Class II1 1 12.5 5.4 4.7
2 12.9 3.4 3.7
3 12.0 4.6 5.1
Mean 12.5 6 0.5 4.5 6 1.1 4.5 6 0.8
Class II2 1 6.9 2.3 2.7
2 5.5 2.3 3.3
3 5.3 2.1 2.3
Mean 5.9 6 1.0 2.2 6 0.2 2.8 6 0.5
Intrathymic
transfer Mouse no.
CD41 B6 cells in spleen CD41 B6.PL cells in spleen
Exp. 2 Percent No. 3 106 No. 3 106
100% B6 1 1.9 2.5 N/A
®MHC I1II2 2 2.3 2.9 N/A
3 2.0 2.3 N/A
Mean 2.1 6 0.2 2.6 6 0.3 N/A
99% B68lo 1 1 1.7 2.5 N/D
1% B6.PL CD82 2 2.1 2.9 N/D
®MHC I1II2 3 1.7 2.1 N/D
Mean 2.2 6 0.5 2.5 6 0.4 N/D
90% B68lo 1 1 2.1 1.9 0.07
10% B6.PL CD82 2 1.7 1.5 0.05
®MHC I1II2 3 1.8 1.8 0.06
Mean 1.9 6 0.3 1.7 6 0.2 0.07 6 0.01
100% B6 1 4.2 9.0 N/A
®MHC I2II2 2 4.1 7.3 N/A
3 3.8 11.2 N/A
4 3.5 8.8 N/A
5 2.9 6.9 N/A
Mean 3.7 6 0.6 8.6 6 1.7 N/A
In Exp. 1, 2 3 106 donor B6.Ly-5.2 CD8loCD4hi cells were injected intrathymically into CD42/2 class II1 (Class II1) or class II2/2 (Class II2) Ly-
5.1 recipients. For Exp. 2, CD8loCD4hi CD11c2 class II2 cells were isolated from B6 mice by cell sorting at .99% purity (with class II1, CD11b1,
and CD11c1 cells undectable by FCM) and were injected into MHC class II2 recipients alone, or after mixing with 1 or 10% CD82CD4lo cells from
B6.PL mice, to control for the level of possible contamination and outgrowth. An aliquot of CD8loCD4lo cells was also injected into CI/II2 recipi-
ents. Cell number was always kept constant at 8.5 3 105. The recipients were analyzed 5 mo later, as described in Materials and Methods. Results
are represen-tative of two experiments. The percentage of CD41Ly-5.11 (host) cells in unmanipulated control mice of the recipient type was 0.0 in
the peripheral organs of CD42/2 class II1 mice, up to 1.7 6 0.5 in the class II2 mice and ,0.1 in CI/II2 mice. This background was subtracted from the
results. N/A, not applicable; ND, not detectable.
*The number of CD41 cells of donor origin in the spleen and mLNs was calculated from the percentages of CD41Ly-5.21 cells obtained by FCM and
the cellularity of the organ, obtained by trypan blue vital dye counting. The cellularity of the spleens was in the range of 50–85 3 106 cells/spleen,
whereas that of the mLNs ranged 9–17 3 106 cells/mLN.762 Final Intrathymic Maturation of CD41 Cells Is Class II Independent
eral progeny of intrathymically transferred CD8loCD4hi
cells was able to survive for .5 mo in the absence of MHC
class II molecules (albeit the numbers were z50–60% of
those in class II1 mice 5 mo after the transfer). This survival
was not due to the outgrowth of contaminating mature
CD82CD4hi thymocytes (Table II) nor to the contaminat-
ing class II1 cells (which were undetectable in the inocu-
lum). We conclude that MHC class II molecules are not
necessary for the long-term survival of at least some CD4 T
cells, but are required for their optimal expansion and ho-
meostasis, since both the percentages and the absolute
numbers of CD41 T cells were about twofold higher in the
presence of class II molecules. The issue of whether MHC
molecules are required and necessary for the survival of pe-
ripheral T cells has recently gained much attention. Al-
though it appears that MHC class I molecules are necessary
for the survival of CD81 cells (27–30), the consensus is
more tenuous in the case of CD41 cells (22, 31–33).
Takeda et al. (31) using the transfer of fetal thymic lobes
into CII2 mice, concluded that class II molecules are not
essential for survival but affect the half-life of CD4 cells.
Rooke et al. (22) reported on a model of retroviral recon-
stitution of class II expression in CII2 mice, and found that
the half-life in reconstituted mice that expressed no class II
in the periphery was similar to that of Takeda et al. (31).
These authors concluded that the lack of class II molecules
curtailed (but did not abolish) the survival of CD41 cells,
and showed that the lack of class I molecules did not fur-
ther pronounce this curtailment. In these experiments, the
uneven expression of intrathymically injected and retrovi-
rus-driven class II molecules could have caused a situation
in which class II molecules were not expressed in all the in-
trathymic compartments relevant to the T cell longevity.
This could have resulted in a paucity of intrathymic signals
that regulate the half-life of T cells, thus reducing the num-
bers of long-lived cells or their half-life. By contrast, the
study of Brocker (32) argued for an absolutely essential role
of class II on peripheral APCs in the survival of CD4 T
cells, based on the results of transplantation of the APC-
depleted class II1 thymi into CII2 mice bearing no trans-
genes or expressing an MHC class II transgene on DCs
alone. In these experiments, good repopulation and in-
trathymic differentiation of CD4 T cells were observed,
but no extrathymic CD4 T cells were detected unless the
DCs expressed the class II transgene. Brocker postulated
that class II molecules are essential for survival of CD4 T
cells. Kirberg et al. (33) showed that CD4 T cells bearing a
TCR transgene required self class II molecules for long-
term survival in the periphery. Finally, Viret et al. showed
that the CD4 T cell repertoire is incompletely maintained
when a single peptide is present on the majority of MHC
class II molecules (34).
Our data certainly agree with all of the above studies in
that class II molecules are required for optimal CD41 ex-
pansion and the filling up of the peripheral compartment.
But our results, together with those of Takeda et al. (31),
also clearly show that a substantial proportion of peripheral
CD4 T cells do not require MHC class II molecules. Re-
sults of Viret et al. (34) are also compatible with this no-
tion, since these authors saw a reduction, but not disap-
pearance, of CD4 T cells in mice unable to exchange the
class II–associated invariant chain peptides for other peptides,
owing to a lack of H-2Ma. However, the period of observa-
tion in these experiments was rather short. In distinction to
the studies of Kirberg et al. (33), we used polyclonal T cells,
and it is quite possible that only some cells from the original
inoculum have survived, reflecting the requirement of some,
but not all, cells for the particular MHC class II ligand. It is
possible that in our system, we have selected for only those
cells that do not require class II for peripheral survival, and
we are testing this possibility at present. We are also investi-
gating whether these cells express a diverse repertoire, as
suggested by their vigorous response to alloantigens (Table
III). At face value, our data appear contrary to those of
Brocker (33). However, these differences can be reconciled
if class II molecules, expressed on hematopoietic cells rather
than being essential for CD4 T cell survival, are necessary
for the export of selected CD4 cells from the thymus. If
this is the case, both studies would have to be reinterpreted
slightly. In our study, then, the transferred CD8loCD4hi cells
either would already have received class II–mediated signals
before transfer, or would have been contaminated with suffi-
cient numbers of class II1 cells to provide this signal after
transfer. We believe that the latter possibility is highly un-
likely, for two reasons. First, the magnetic bead separation
retains most DCs and Mf on the columns nonspecifically,
and since the largest theoretical contamination of the inoc-
Table III. The Progeny of Intrathymically Transferred 
CD8loCD4hi Develops into Functional CD41 Peripheral T Cells 
Regardless of the Presence of MHC Class II Molecules
Exp. 1 CD4 donors
Stimulator cells
Control B6 bm12 bm1
B6 420 580 8,580 ND
CD8lo®class II1 340 870 8,010 ND
CD8lo®class II2 340 380 5,520 ND
bm12 400 9,880 890 ND
Exp. 2
B6 990 1,560 12,300 2,300
CD8lo®class II1 560 980 6,750 1,180
CD8lo®class II2 790 1,200 5,300 1,050
bm12 1,060 17,660 570 870
Tissue culture supernatants from the above MLRs were collected after
96 (Exp. 1) or 72 h (Exp. 2), and assayed for the IL-2 content as de-
scribed in Materials and Methods. Shown are the mean cpm from trip-
licate determinations. SD did not exceed 10% in any combination. Re-
sults are representative of three experiments. The numbers denoting
significant proliferation are in bold.763 Dyall and Nikoli - ugi c ´ Z ˘ c ´
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ulum with CD42 cells was in the range of 600–800 cells
(see Fig. 1), even assuming all of these cells were MHC
class II1, this number appears too small to permit substan-
tial proliferation and export of maturing thymocytes. Sec-
ond, the presence of class II1, CD11c1, or CD11b1 cells
was undetectable among FCM-sorted inoculated thy-
mocytes (see legend to Table II). In the experiments of
Brocker (32), the class II1 DCs would provide their essen-
tial export signal intrathymically (indeed, DCs are well
known to reside in the thymus [2]), and would also help
the CD4 expansion in the periphery. The first function
would be absolutely critical, and its lack would mean that
no CD4 T cells could be detected in CII2 mice grafted
with class II1 epithelium.
Finally, with regard to CD4 T cell homeostasis, our
study demonstrated that the proliferation of the injected
thymocytes can occur in the absence of class II molecules,
as well as in the absence of class I1 APCs. Interestingly, this
proliferation was particularly pronounced in CI/II2 mice,
paralleling the findings of Rooke et al. (22). At present, it is
unclear whether the SP thymocytes in our study prolifer-
ated intrathymically (10, 11) or whether the proliferation
occurred in the periphery, and additional studies will be
needed to address this issue.
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